Scope and methodology
Perioperative and critical care bleeding is a common clinical emergency for which hospitals need to develop major hemorrhage protocols [1] . The incidence of major bleeding will differ depending upon the type of surgery, procedure performed, surgical technique and any pre-existing coagulopathy. There is ongoing debate surrounding the utility of viscoelastic methods in the management of major bleeding. A recent meta-analysis has shown that the use of the viscoelastic method for guiding hemostatic treatment in bleeding patients decreases blood product transfusion and mortality, but this was mostly based on results from elective cardiac surgery using cardiopulmonary bypass and therefore generalization to other patient groups is not possible. In other recent metaanalyses of the use of viscoelastic methods in cardiac surgery, a reduction in the use of blood components, but not clinical outcome, was seen, reflecting ongoing uncertainty in this area [2, 3] .
This guidance contains a brief summary of the published evidence. It will not discuss the underlying scientific principles of viscoelastic methods, which have been described elsewhere [4] . Neither will this guidance advise on the best clinical protocol algorithms to guide specific blood product usage according to viscoelastic method parameter triggers, because these have not been validated in randomized controlled trials. Instead, institutions will need to agree on local protocols and reference ranges. It is assumed that readers of this guidance will be skilled in the interpretation of viscoelastic methods and how this may guide hemostatic treatments. Independent of any application of viscoelastic methods, it is critical that on introduction to an institution there is sufficient support with staff training, clinical protocols for the use of blood products according to findings on the viscoelastic method, on-hand expertise, and a quality assurance program for the device with clear responsibility for each of these areas.
Obstetric hemorrhage and the use of viscoelastic methods have been covered elsewhere by International Society on Thrombosis and Hemostasis guidance [5] . The use of viscoelastic methods in trauma is currently still under evaluation in clinical trials (the largest being iTACTIC, due to report in 2018) and will not be covered by this guidance [6] . The nature of this review excludes coverage of the use of platelet mapping cartridges. Direct oral anticoagulants (DOAC) and the effect of these agents on viscoelastic methods have been described and this is still investigational. As yet, validation of viscoelastic methods to provide measurement of the effect of DOACs is awaited [7] .
The wording 'we recommend' indicates a strong consensus among the authors, whereby the clinician should consider adopting the practice in most cases. ' We suggest' reflects a weak guidance statement with moderate consensus among the panel members, whereby the clinician may adopt the guidance or use an alternative approach. Conventional coagulation tests (CCTs) are defined as the prothrombin time (PT), activated partial thromboplastin time (APTT), Clauss fibrinogen and full blood count. Viscoelastic methods are defined as thromboelastography (TEG) and rotational thromboelastometry (ROTEM), except the TEG6s, which uses a resonance method for which there is little validation yet.
Uniquely, viscoelastic methods assess clot stability and fibrinolytic activation but they do have some important limitations. Firstly, a full blood count may be needed in combination with viscoelastic methods to accurately determine the hemoglobin level and platelet count to help guide red blood cell and platelet transfusion, and it should be noted that the hematocrit will influence the viscoelastic results [8] . Secondly, viscoelastic methods are insensitive to antiplatelet agents and therefore cannot give information on acquired platelet dysfunction. Lastly, although they do detect fibrinolytic activation, this is not sensitive or reliable and can miss major fibrinolytic activation [9, 10] . Two devices are widely used: the TEG Ò (Haemoscope Corporation, Niles, IL, USA) and ROTEM Ò (Instrumentation Laboratory, Werfen, Barcelona, Spain). The currently available models are the TEG500 and the TEG6s; the latter is small, portable and automated but does not use a thromboelastographic method; however, previous versions do. It requires a cartridge to have a small sample of blood placed in it and then be inserted into the analyzer, allowing four channels to be analyzed simultaneously. The current ROTEM is ROTEM delta, which also has four channels, allowing the study of four samples simultaneously. The TEG and ROTEM have different tests available to assess different components of hemostasis (see Table 1 ); their utility depends on the clinical situation faced. The ROTEM has variable reproducibility with a coefficient of variation for maximum clot firmness of < 3% for EXTEM, < 5% for INTEM and < 6% for FIBTEM; for clot formation time the coefficient of variation was < 4% for EXTEM and < 3% for INTEM; for alpha angle the coefficient of variation was < 3% for EXTEM and 6% for INTEM and the coefficient of variation was < 15% for both EXTEM and INTEM [11] . However, The United Kingdom National External Quality Assessment Scheme for coagulation showed precision was variable, with coefficients of variation ranging from 7.1% to 39.9% for TEG and from 7.0% to 83.6% for ROTEM [12] . The ROTEM coefficient of variation compared favorably with the TEG but currently there is inadequate published head-to-head comparisons between the devices to make any recommendations between devices. Furthermore, new TEG and ROTEM equipment has been made available to the market, so further studies are required [13] .
What is the utility of viscoelastic methods within cardiac surgery?
Several reviews have assessed the increasing use of viscoelastic methods within cardiac surgery using cardiopulmonary bypass. In 2012 a randomized controlled study demonstrated the superiority of a viscoelastic methodbased algorithm for bleeding in cardiac surgery compared with CCTs, with a decrease in transfusion in the viscoelastic-method group, a mortality benefit at 6 months and decreased intensive care and hospital stay [14] . In 2013 two reviews were published that assessed the role of viscoelastic methods within cardiac surgery, but viscoelastic methods were not compared with CCTs in all the trials included (they were compared with clinical judgment). In the first, 16 trials involving 8507 cardiac surgery patients between 1995 and 2012 were analyzed [15] . The use of viscoelastic methods with transfusion algorithms decreased transfusion requirements. In the second review, 12 trials including 6835 patients, the proportion of patients requiring transfusion of blood products was significantly reduced by the use of viscoelastic methods [16] . In 2014 the United Kingdom National Institute for Clinical Excellence evaluated 11 trials and concluded not only that usage led to reduced transfusion requirements but it was also cost effective, and they recommended ROTEM and TEG to monitor hemostasis during and after cardiac surgery [17] .
Three recent meta-analyses have further explored this issue; however, it should be noted that viscoelastic methods were not compared with CCTs (they were compared with clinical judgement) in all of the trials included. In two studies, use of viscoelastic methods significantly decreased exposure to allogeneic blood products [18, 19] . One study suggested that thromboembolic events, surgical re-exploration and postoperative acute kidney injury are reduced by using viscoelastic methods [18] . The other study suggested that dialysis-dependent renal failure was reduced by viscoelastic methods [19] 
Guidance statements
1. We recommend that viscoelastic methods are used in cardiac surgery to guide blood product and hemostatic support.
What is the utility of viscoelastic methods within liver transplant surgery?
During liver transplantation, if no active liver support is provided to the donor liver pre-transplantation, there is a massive release of tissue plasminogen activator produced by the hypoxic donor liver endothelium into the systemic circulation, once connected to the recipient's circulation. Viscoelastic method algorithms, in comparison to CCTs, to guide blood product and hemostatic support have been extensively studied in retrospective studies [20] [21] [22] [23] . Preoperative ROTEM has also been used to predict blood product requirements in adult living donor transplant recipients [24] . One small randomized control trial in 28 patients randomized to either TEG-guided transfusion or transfusion using conventional laboratory tests showed that TEG can reduce fresh frozen plasma (FFP) use during liver transplant [25] . In a recent retrospective study of 234 patients admitted to the intensive care unit after liver transplant, CCTs and ROTEM were compared with regard to prediction of bleeding in the 48 h after surgery. ROTEM-FIBTEM was superior to plasma fibrinogen in predicting postoperative bleeding; the authors concluded that ROTEM-FIBTEM, which reflects fibrin polymerization, could be used to develop future algorithms and the need to supplement fibrinogen [26] . Overall, there is no consensus on protocols for or the benefit of viscoelastic methods during liver transplantation, despite their 50-year use to guide blood products and hemostatic therapy in this setting.
2. We suggest that viscoelastic methods can be used to guide hemostatic support during liver transplant surgery, rather than CCTs.
What is the utility of viscoelastic methods in general surgery?
There are very limited data on the utility of viscoelastic methods in general surgery. One trial of 30 patients requiring excision of burns, performed on the third day after trauma, showed that compared with the clinician's discretion a ROTEM-based algorithm for guiding blood product transfusion reduced blood product usage: a mean of 3.0 (IQR, 1.3-5.5) blood products vs. 9.0 (IQR, 6.0-12.3); no FFP administered in the viscoelastic methods group vs. 5.0 (IQR, 1.5-7.5) [27] . Notably, tranexamic acid was not given to patients in this study, which would now be standard care in several European countries for operations with an estimated blood loss of more than 500 mL [28] . Overall, the utility of viscoelastic methods in general surgery has been inadequately studied and therefore, because of the lack of supporting evidence, different bodies are not supportive of their use.
3. There is currently insufficient evidence to recommend the use of viscoelastic methods over conventional laboratory coagulation tests in general surgery.
Can viscoelastic methods help manage the risk of venous and arterial thromboembolism postoperatively?
In 2009, a systematic review of 10 published studies involving 1056 patients assessed preoperative TEG's ability to predict the risk of postoperative hospitalacquired venous thromboembolism. The studies were of variable quality and the authors concluded that more prospective studies are required [29] . Recent prospective observational studies in cardiac surgery have demonstrated that preoperative TEG is, at best, a very weak predictor of postoperative thrombosis in the cardiac and non-cardiac setting [30, 31] . Two small randomized controlled trials failed to show a benefit in using the viscoelastic method to guide the dosage of low-molecular-weight heparin thromboprophylaxis compared with standard dosing, for reducing the rate of postoperative venous thromboembolism [32, 33] .
4. There is insufficient evidence to recommend the preoperative use of viscoelastic methods for prediction of risk of postoperative venous and arterial thromboembolism or adjustment of pharmacological thromboprophylaxis.
What is the utility of viscoelastic methods in evaluating bleeding risk preoperatively?
Viscoelastic methods were shown to have poor sensitivity and specificity for bleeding disorders in adults referred for investigation of bleeding symptoms (in a series of 195 patients) [34] . It is not recommended to rely on viscoelastic methods to perform regional anesthesia. A recent trial, involving 60 patients with liver cirrhosis and an INR > 1.8 or a platelet count of < 50 9 10 9 /L randomized to either TEG-guided transfusion or conventional care (using platelet count and INR to guide transfusion), demonstrated that TEG significantly decreased blood product usage without increasing postprocedure bleeding when used to assess the need for fresh frozen plasma (FFP) or platelet infusions before invasive procedures [35] . Remarkably, 100% of patients in the standard laboratory group in that trial received blood products (FFP, platelets or both) pre-procedure compared with 16.7% in the TEG group, suggesting that some physicians have more confidence in viscoelastometry than CCTs.
5. Routine use of viscoelastic methods to screen for bleeding risk during surgery is not recommended. 6. We do not recommend the use of viscoelastic methods to determine the bleeding risk in those with abnormal CCT, including those with liver disease, because of a lack of evidence for this approach.
Conclusions
In conclusion, we offer pragmatic recommendations reflecting current evidence for use of viscoelastic methods. Viscoelastic methods are widely available and used in managing intraoperative bleeding, but good evidence demonstrating improvement in clinical outcome is lacking, except in cardiac surgery. Further research needs to be undertaken in many areas, but especially to establish algorithms for the use of viscoelastic methods and how they compare with conventional laboratory tests (as many trials compared viscoelastic methods with clinician's discretion regarding transfusion), as well as outcomes. Furthermore, recent evidence [9, 10] shows that viscoelastic methods are an insensitive marker of fibrinolysis, and whether they have any utility within the context of widespread use of perioperative tranexamic acid to prevent bleeding needs exploring. 
